ClinicalTrialsFinder

HER2 Positive Malignancies Clinical Trials in Chengdu, Sichuan

1 recruitingChengdu, Sichuan, China

Showing 1–1 of 1 trials

Recruiting
Early Phase 1

Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

Pleural Effusion, MalignantPeritoneal Carcinoma MetastaticHER2 Positive Malignancies
Sichuan University18 enrolled1 locationNCT04684459